Table 1.
Characteristics at SWAN HDL Baseline
| Variable | N=471 |
|---|---|
| Age, years, mean (SD) | 50.19(2.7) |
| Race, n(%) | |
| White | 244(51.8%) |
| Black | 130(27.6%) |
| Chinese | 52(11.0%) |
| Hispanic | 3(0.6%) |
| Japanese | 42(8.9%) |
| Education, n(%) | |
| High School or less | 83 (17.7%) |
| Some College/College | 249 (53.1) |
| Post-Graduate | 137(29.2%) |
| Menopausal Status, n(%) | |
| Pre/Early Peri-menopausal | 374(79.4%) |
| Late Peri-menopausal | 37(7.9%) |
| Postmenopausal | 51(10.8%) |
| Unknown due to HT use | 9 (1.9%) |
| Ever Use Hormone, n(%) | 46 (9.8%) |
| Use any of antilipemic, antidiabetic or antihypertensive medication, n(%) | 75 (15.9%) |
| Time relative to FMP, years, median (Q1, Q3) | −2.08(−3.54, −0.78) |
| BMI, kg/m2, median (Q1, Q3) | 26.54(22.95, 31.71) |
| C3, mg/dl, mean (SD) | 125.01(29.24) |
| Total Cholesterol, mg/dL, mean (SD) | 193.93(34.06) |
| LDL-C, mg/dL, mean (SD) | 112.40(31.03) |
| HDL-C, mg/dL, mean (SD) | 59.32(14.22) |
| Triglycerides, mg/dL, median (Q1, Q3) | 112.55(78.69) |
| apoA1, mg/dl, mean (SD) | 163.63 (26.16) |
| Total HDL-P, umol/L, mean (SD) | 34.67(5.97) |
| Large HDL-P, umol/L, mean (SD) | 8.49(3.59) |
| Medium HDL-P, umol/L, mean (SD) | 11.19(6.19) |
| Small HDL-P, umol/L, mean (SD) | 14.99(7.03) |
| HDL Size, nm, mean (SD) | 9.54(0.54) |
| HDL-PL, mg/dL, mean (SD) | 54.15(10.26) |
| HDL-Tg, mg/dL, median (Q1, Q3) | 17.00(14.00, 21.00) |
| HDL-CEC, %, mean(SD) | 3.95(0.67) |
apoA1: apolipoprotein A1; BMI: body mass index; C3: complement protein C3; E2: estradiol; FMP: final menstrual period; HDL-C: high-density lipoprotein cholesterol; HDL-CEC: high-density lipoprotein cholesterol efflux capacity; HDL-P: high-density lipoprotein particles; HDL-PL: high-density lipoprotein phospholipids; HDL-Tg: high-density lipoprotein triglycerides; LDL-C: low-density lipoprotein cholesterol.